MX2008011454A - Uso novedoso de agentes antihistaminicos para el tratamiento preventivo o temprano de sindromes inflamatorios, en particular los que son accionados por togavirus. - Google Patents

Uso novedoso de agentes antihistaminicos para el tratamiento preventivo o temprano de sindromes inflamatorios, en particular los que son accionados por togavirus.

Info

Publication number
MX2008011454A
MX2008011454A MX2008011454A MX2008011454A MX2008011454A MX 2008011454 A MX2008011454 A MX 2008011454A MX 2008011454 A MX2008011454 A MX 2008011454A MX 2008011454 A MX2008011454 A MX 2008011454A MX 2008011454 A MX2008011454 A MX 2008011454A
Authority
MX
Mexico
Prior art keywords
togaviruses
preventive
inflammatory syndromes
early treatment
those triggered
Prior art date
Application number
MX2008011454A
Other languages
English (en)
Inventor
Jean Deregnaucourt
Etienne Andre
Jacky Tisne-Versailles
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MX2008011454A publication Critical patent/MX2008011454A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al uso de por lo menos un agente antihistamínico para la preparación de un medicamento para el uso en el tratamiento preventivo o temprano de síndromes inflamatorios de origen viral, en particular la artritis de las articulaciones distales, más particularmente aquellas que son accionadas por togavirus, la invención también se refiere a un producto de combinación de por lo menos un agente antihistamínico y de por lo menos un agente antiserotonina para su uso simultáneo separado o secuencial en la terapia preventiva o temprana para síndromes inflamatorios de origen viral, en particular la artritis de las articulaciones distales, más particularmente aquellas que son accionadas por togavirus.
MX2008011454A 2006-03-09 2007-03-09 Uso novedoso de agentes antihistaminicos para el tratamiento preventivo o temprano de sindromes inflamatorios, en particular los que son accionados por togavirus. MX2008011454A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602087A FR2898271B1 (fr) 2006-03-09 2006-03-09 Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou procede de syndromes inflammatoires, en particulier ceux declenches par les toga virus.
PCT/EP2007/052237 WO2007101884A1 (fr) 2006-03-09 2007-03-09 Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou precoce de syndromes inflammatoires, en particulier ceux declenches par les togavirus.

Publications (1)

Publication Number Publication Date
MX2008011454A true MX2008011454A (es) 2008-09-24

Family

ID=37075926

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008011454A MX2008011454A (es) 2006-03-09 2007-03-09 Uso novedoso de agentes antihistaminicos para el tratamiento preventivo o temprano de sindromes inflamatorios, en particular los que son accionados por togavirus.

Country Status (11)

Country Link
US (1) US8242110B2 (es)
EP (1) EP2007394B1 (es)
JP (1) JP5550836B2 (es)
KR (1) KR101450345B1 (es)
CN (1) CN101394854A (es)
AP (1) AP2910A (es)
BR (1) BRPI0709006A2 (es)
FR (1) FR2898271B1 (es)
MX (1) MX2008011454A (es)
WO (1) WO2007101884A1 (es)
ZA (1) ZA200807442B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0620468A2 (pt) 2005-12-22 2011-11-08 Transtech Pharma Inc ácidos fenóxi acéticos como ativadores de ppar delta
CN102028692B (zh) * 2010-12-01 2012-08-22 中国人民解放军第二军医大学 酮色林的应用
CN103690522B (zh) * 2013-12-08 2015-05-06 武汉威立得生物医药有限公司 一种草酸萘呋胺在制备治疗或预防流感病毒药物中的应用
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
SG11202003886TA (en) * 2017-11-01 2020-05-28 Nat Univ Singapore Use of serotonergic drugs to treat virus-induced thrombocytopenia
CA3138008A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
US11071739B1 (en) 2020-09-29 2021-07-27 Genus Lifesciences Inc. Oral liquid compositions including chlorpromazine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3726976A (en) * 1968-03-20 1973-04-10 J Glasser Treatment of arthritis with combinations of antihistaminic compounds and diuretics
JPH0489428A (ja) * 1990-07-30 1992-03-23 Kao Corp 多形核白血球活性化剤
US5492689A (en) * 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
JPH08239327A (ja) * 1995-03-03 1996-09-17 Taisho Pharmaceut Co Ltd 慢性骨格筋疼痛の予防又は治療剤
JP2001151677A (ja) 1999-11-26 2001-06-05 Taisho Pharmaceut Co Ltd 咽頭用組成物
FR2802101B1 (fr) * 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique

Also Published As

Publication number Publication date
WO2007101884A1 (fr) 2007-09-13
AP2910A (en) 2014-05-31
EP2007394A1 (fr) 2008-12-31
CN101394854A (zh) 2009-03-25
ZA200807442B (en) 2009-07-29
JP2009529514A (ja) 2009-08-20
US20090069308A1 (en) 2009-03-12
FR2898271B1 (fr) 2009-01-16
AP2008004613A0 (en) 2008-10-31
JP5550836B2 (ja) 2014-07-16
KR101450345B1 (ko) 2014-10-14
KR20080107410A (ko) 2008-12-10
US8242110B2 (en) 2012-08-14
BRPI0709006A2 (pt) 2011-06-21
EP2007394B1 (fr) 2012-10-10
FR2898271A1 (fr) 2007-09-14

Similar Documents

Publication Publication Date Title
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
MX2008011454A (es) Uso novedoso de agentes antihistaminicos para el tratamiento preventivo o temprano de sindromes inflamatorios, en particular los que son accionados por togavirus.
MY198422A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
EP2056818A4 (en) COMPOSITIONS AND METHODS FOR NEUROPROTECTION
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
TW200738724A (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
IL195142A (en) Processed arylaimidazolone and triazolone, their preparation process, pharmaceutical preparations containing them for the treatment or prevention of diseases
WO2007058990A3 (en) Therapy using cytokine inhibitors
TW200806300A (en) New therapeutic combinations for the treatment of depression
IL206296A (en) History of aminopyrazole, and their medicinal products and their use in the preparation of drugs for the prevention and treatment of diseases
PT2383271E (pt) Aminoquinolonas como inibidores de gsk-3
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
BRPI0816255A2 (pt) Produto farmacêutico, uso do produto, método para a profilaxia ou o tratamento de doenças, e, composição farmaceuticamente aceitável
EA200701820A1 (ru) Применение диосметиновых соединений при лечении и профилактике тромботических патологий
HK1130011A1 (en) Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative
WO2006074265A3 (en) Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
MX2010006204A (es) Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MX2010007083A (es) Combinacion anti-retroviral.
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
AR062658A1 (es) Terapias de combinacion para artritis reumatoide
WO2005099749A3 (en) Methods for controlling angiogenesis and cell proliferation

Legal Events

Date Code Title Description
FG Grant or registration